When it received FDA approval in 2011, the pharmaceutical Xarelto (rivaroxaban) was seen as the new era of anti-coagulant drugs (blood thinners). It was suggested to replace drugs like Warfarin (brand names include Coumadin, Jantoven, Marevan, Uniwarfin) that have been in use since 1954. There have been a lot of concerns about Xarelto’s safety and … Read More